(Q96231810)

English

Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics

scientific article published on 10 June 2020

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32518941%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32518941%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

based on heuristic

inferred from title

spike glycoprotein [SARS-CoV-2]

1 reference

based on heuristic

inferred from abstract

protein glycosylation

1 reference

based on heuristic

inferred from abstract

author name string

Dapeng Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32518941%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Xiaoxu Tian

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32518941%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ruibing Qi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32518941%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Chao Peng

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32518941%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Wen Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32518941%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

0 references

publication date

10 June 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32518941%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32518941%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Mucin-type fusion proteins with blood group A or B determinants on defined O-glycan core chains produced in glycoengineered Chinese hamster ovary cells and their use as immunoaffinity matrices.

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lung

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Rapid generation of a mouse model for Middle East respiratory syndrome

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1093/GLYCOB/CWAA052

13 August 2020

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q96231810&oldid=1780485147"